At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases.

AstraZeneca is leading a revolution in oncology with the ambition to provide cures for cancer in every form, following the science to understand cancer and all its complexities to discover, develop and deliver life-changing medicines to patients. The Company’s focus is on some of the most challenging cancers. It is through persistent innovation that AstraZeneca has built one of the most diverse portfolios and pipelines in the industry, with the potential to catalyse changes in the practice of medicine and transform the patient experience. AstraZeneca has the vision to redefine cancer care and, one day, eliminate cancer as a cause of death.

Roche New Zealand operates across two businesses, Pharmaceuticals and Diagnostics. Our aim is to enable New Zealanders access to our medicines and diagnostic tests to detect illnesses early, and to treat them with life-saving and life-changing medicines. Because every person is unique, we are working to advance the concept of personalised healthcare – helping to prevent, diagnose and treat illnesses more effectively. Roche is the largest investor in clinical trials in New Zealand, with approximately 50 active clinical trials running at any given time across a range of disease areas. We have one purpose: to do now what patients need next.

Canopy Cancer Care is a leading private provider of specialist oncology and haematology services across New Zealand, dedicated to delivering world-class treatment and care. Since 2010, Canopy has expanded to eight clinics across the North Island, including Whangārei, Warkworth, Milford, Epsom, Tauranga, Rotorua, and Hastings. As part of the Canopy Healthcare family, which also offers diagnostic imaging, specialist breast imaging, surgical services, and drug compounding, Canopy delivers an integrated approach to healthcare that enhances patient outcomes.

The Canopy vision is to offer New Zealanders world-class cancer care, delivered locally. Their expert team of medical oncologists, haematologists, nurses, and support staff provides personalised treatment plans tailored to the needs of each patient, ensuring access to the latest advancements in cancer therapies such as chemotherapy, immunotherapy, and targeted treatments. Compassionate care is at the heart of their approach, supporting both patients and their whānau through every step of their cancer journey.

Canopy Cancer Care is proud to contribute to the Cancer Society’s "In Pursuit" conference, joining others in advancing knowledge, collaboration, and care in the fight against cancer. Their mission is to make a positive difference in the lives of those they serve, every day and with every patient.

IGENZ is an Auckland based private medical laboratory established in 2006. We are focused on genomic testing and molecular diagnostics, specialising in cancer diagnostics, targeted testing, and preventative screening tests.

Advances in genomic testing are rapidly transforming primary care, enabling earlier detection, and personalised, evidence-based choices. Our team uses leading-edge molecular technologies to provide reliable, accurate results that support informed decision-making in patient care.

The St George’s Cancer Care Centre is dedicated to treating and supporting cancer patients through an integrated approach to care, from radiation, chemotherapy and haematology to psychology nutrition and exercise advice. As the largest private provider of cancer care services in the South Island, we provide patients with another choice outside of the public system for cancer treatment, notably offering shorter waiting times, access to non-Pharmac funded drugs, and advanced treatment through innovative equipment and evidence-based protocols.

We are proud to bring world-class cancer treatment to patients across New Zealand. In addition to our main treatment facility in Christchurch where we house New Zealand’s first MRI linear accelerator offering the only non-invasive personalised radiation treatment in the country, we have remote clinics in Invercargill, Queenstown, Dunedin, and our latest location, Nelson, launching in early 2025. In partnership with Dunstan Hospital, we also offer our Chemo Close to Home service in Clyde which provides vital chemotherapy treatment in a supportive, local environment. Extending our reach and providing cancer care facilities throughout the South Island is just one more way we are leading the fight against cancer in New Zealand.

Cyclone is a privately owned New Zealand company with branches in Auckland, Wellington, Christchurch, Dunedin and Invercargill. As a comprehensive IT solutions provider, they offer a wide range of services, including hardware procurement, software licensing, managed and project services. Cyclone supports government agencies, medium and large enterprises, and educational institutions across New Zealand, focusing on delivering customised IT solutions and maintaining strong customer relationships.

For 30 years, their commitment to innovation and customer service has established them as a trusted partner in the IT industry.

Cyclone is also a proud partner of the Southern Cancer Society of New Zealand Inc.

AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: oncology, immunology, neuroscience, eye care, virology and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. Our heritage in New Zealand reaches back more than 80 years and we employ around 30 people with our therapies currently benefiting more than 5,000 New Zealanders.